CollPlant Biotechnologies (CLGN) Finished Goods (2022 - 2025)

CollPlant Biotechnologies has reported Finished Goods for 4 years, with the latest figure at $290000.0 in Q4 2025.

• For the quarter ending Q4 2025, Finished Goods rose 88.31% year-over-year to $290000.0; the trailing twelve-month figure through Dec 2025 stood at $290000.0 (up 88.31% YoY), and the FY2025 full-year result was $290000.0, up 88.31% from the prior year.
• Finished Goods for Q4 2025 stood at $290000.0, up from $154000.0 in the prior quarter.
• The five-year high for Finished Goods was $549000.0 in Q4 2022, with the low at $154000.0 in Q4 2024.
• Historically, Finished Goods has averaged $383500.0 across 4 years, with a median of $415500.0 in 2023.
• Annual changes were most pronounced in 2024 — Finished Goods slumped 71.53% — and 2025, when it soared 88.31%.
• CollPlant Biotechnologies' Finished Goods stood at $549000.0 in 2022, then decreased by 1.46% to $541000.0 in 2023, then tumbled by 71.53% to $154000.0 in 2024, then soared by 88.31% to $290000.0 in 2025.
• The last three Finished Goods figures came in at $290000.0 (Q4 2025), $154000.0 (Q4 2024), and $541000.0 (Q4 2023), per Business Quant data.